Meitav Dash Investments »

Neurocrine Biosciences shares owned by Meitav Dash Investments

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Meitav Dash Investments from 13F filings

Historical chart of Meitav Dash Investments investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Meitav Dash Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Meitav Dash Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.8M 13k 141.83
2024-03-31 $793k 5.8k 137.92

More positions owned by Meitav Dash Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr State Street Com (XLC)
Nike CL B (NKE)
Select Sector Spdr Tr State Street Fin (XLF)
Vaneck Etf Trust Semiconductr Etf (SMH)
Select Sector Spdr Tr State Street Hea (XLV)
Tower Semiconductor Shs New (TSEM)
Elbit Sys Ord (ESLT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
NOVA MEASURING Instruments L (NVMI)
Enlight Renewable Energy SHS (ENLT)

View all positions for Meitav Dash Investments

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Dodge & Cox
Jpmorgan Chase & Co
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Wellington Management Company
Bellevue Group
Bnp Paribas Investment Partners
Thomas Stevens, CFA"
Northern Trust
Deerfield Management Company
Norges Bank Investment Management

View all funds holding Neurocrine Biosciences